0001628280-24-025893.txt : 20240530 0001628280-24-025893.hdr.sgml : 20240530 20240530174410 ACCESSION NUMBER: 0001628280-24-025893 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240528 FILED AS OF DATE: 20240530 DATE AS OF CHANGE: 20240530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schaeffer Orlov S Nicole CENTRAL INDEX KEY: 0001401017 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30739 FILM NUMBER: 241006899 MAIL ADDRESS: STREET 1: INSMED INCORPORATED STREET 2: 700 US-206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSMED Inc CENTRAL INDEX KEY: 0001104506 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 541972729 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908-977-9900 MAIL ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: INSMED INC DATE OF NAME CHANGE: 20000128 4 1 wk-form4_1717105441.xml FORM 4 X0508 4 2024-05-28 0 0001104506 INSMED Inc INSM 0001401017 Schaeffer Orlov S Nicole 700 US 202/206 BRIDGEWATER NJ 08807 0 1 0 0 Chief People Strategy Officer 1 Common Stock 2024-05-28 4 M 0 27500 12.58 A 136260 D Common Stock 2024-05-28 4 S 0 27500 49.53 D 108760 D Stock Option (right to buy) 12.58 2024-05-28 4 M 0 27500 0 D 2024-06-02 Common Stock 27500 0 D This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. /s/ S. Nicole Schaeffer, by Michael A. Smith as Attorney-in-fact 2024-05-30